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Editorial on the Research Topic
Role of Protein Palmitoylation in Synaptic Plasticity and Neuronal Differentiation
Protein palmitoylation, the reversible addition of palmitate to proteins, is a dynamic post-
translational modification. Both membrane (e.g., channels, transporters, and receptors) and
cytoplasmic proteins (e.g., cell adhesion, scaffolding, cytoskeletal, and signaling molecules) are
substrates. In mammals, palmitoylation is mediated by 23-24 palmitoyl acyltransferases (PATs),
also called ZDHHCs for their catalytic aspartate-histidine-histidine-cysteine (DHCC) domain.
PATs are integral membrane proteins found in cellular membranes. In the palmitoylation cycle,
palmitate is removed by the depalmitoylation enzymes, acyl palmitoyl transferases (APT1 and
2), and α/β Hydrolase domain-containing protein 17 (ABHD17A-C). These are cytoplasmic
proteins that are targeted to membranes where they are substrates for PATs. The second class
of depalmitoylating enzymes are palmitoyl thioesterases, PPT1 and 2, discovered through their
association with infantile neuronal ceroid lipofuscinosis. These are secreted proteins found in the
lumen of intracellular organelles, primarily lysosomes, where their function as depalmitoylating
enzymes is unclear.
Our understanding of protein palmitoylation is still in its infancy, with the most basic questions
still to be addressed. Have all of the proteins involved in the process of palmitoylation been
identified?What are the molecular details for how palmitoylation and depalmitoylation occurs and
how substrates are targeted to and bind to PATs and deplamitoylating enzymes? What roles do the
different PATs and deplamitoylating enzymes play? How is palmitoylation tied to and regulated by
lipid metabolism and other metabolic pathways? How do other post-translational modifications at
overlapping sites on proteins, such as phosphorylation and nitrosylation, regulate palmitoylation
and vice versa?
One area where progress is beingmade is characterizing the different functions of palmitoylation
in neurons. Here several groups have investigated the role of palmitoylation in different cell
biological processes involved in axon growth, synapse formation, synaptic plasticity, and lysosomal
function at synapses. Of special interest are the links these processes have to neurodegenerative
diseases, in particular infantile neuronal ceroid lipofuscinosis and Huntington’s Disease.
Matt et al. review the dynamic cycling of protein palmitoylation and its role in
activity-dependent synapse formation. Palmitoylation of postsynaptic proteins ranges from
neurotransmitter receptors such as the N-methyl-D-aspartate receptor (NMDAR) and
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) to scaffolding
proteins such as postsynaptic density protein 95 (PSD-95). Especially, PSD-95 palmitoylation
is a critical regulator of many aspects of synaptic plasticity. For example, another study
from the same group demonstrates a mechanism by which a reduction in PSD-95
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palmitoylation mediates chemically induced long-term
depression (Chowdhury and Hell). Following calcium influx,
binding of Ca2+/calmodulin to PSD-95 triggers a reduction in
PSD-95 palmitoylation, and disperses the scaffolding protein
and associated AMPARs out of the postsynaptic membrane.
Remarkably, palmitoylation regulates PSD-95 conformation and
orientation, thereby controlling the retention of AMPARs in
PSDs (Jeyifous et al., 2016).
Protein palmitoylation also regulates the structural
remodeling of neuronal processes. Albanesi et al. review
the role of palmitoylation in the structural plasticity of dendritic
spines. Spine remodeling depends on the polymerization,
depolymerization, bundling, and branching of actin filaments.
These processes are controlled by small GTPases and
several other cytosolic proteins. Importantly, reversible
palmitoylation enables their localization within spines in an
activity-dependent manner.
Axonal growth and guidance are also regulated by
protein palmitoylation. Dumoulin et al. report that protein
palmitoylation plays a vital role in axonal bifurcation through
activation of the signaling cascade triggered by the C-type
natriuretic peptide and the receptor guanylyl cyclase Npr2 and
cGMP-dependent protein kinase Iα.
In addition to synaptic membranes, palmitoylation also
regulates the trafficking and functions of proteins in various
organelles, including lysosomes. Sanders et al. have shown that
palmitoylation regulates assembly of the mechanistic target of
rapamycin (mTOR) complex 1 (mTORC1) signaling complex
on lysosomal membranes. Interestingly, lysosomes translocate
to dendritic spines and regulate local protein degradation,
thereby facilitating synaptic remodeling (Goo et al., 2017). These
findings suggest that the balance between palmitoylation and
depalmitoylation regulates not only reversible trafficking but also
proteostasis and autophagy.
A number of the palmitoylation and depalmitoylation
enzymes are associated with various neurological and psychiatric
disorders in children and adults. In Huntington disease,
ZDHHC17 and ZDHHC13, also called huntingtin-interacting
protein 14 (HIP14) and HIP14-like (HIP14L), directly interact
with the huntingtin protein (Htt), and mutant Htt disrupts
this interaction. Kang et al. find that HIP14L palmitoylates the
NMDAR subunit GluN2B in striatal neurons. Consequently,
deficient GluN2B palmitoylation enhances the extrasynaptic
activity of NMDARs, which induces cell death-signaling
pathways underlying neurodegeneration.
The lysosomal depalmitoylation enzyme PPT1 is associated
with infantile neuronal ceroid lipofuscinosis. PPT1 is a crucial
regulator of the autophagy-lysosome pathway and controls
multiple steps of neuronal differentiation ranging from axonal
guidance as well as pre- and post-synaptic functions (Koster
and Yoshii). Especially, Sapir et al. identified the lack of
PPT1 function results in immature dendritic spines and
a reduction in LTP expression. Another recent study also
demonstrates the loss of PPT1 function results in the stagnation
of the developmental subunit switch of the NMDAR subunit
that correlates with immature spine formation. Consequently,
the NMDAR dysregulation underlies the susceptibility to
excitotoxicity (Koster et al., 2019).
Progress in this field has been driven by new technical
advantages that have allowed palmitoylation to be quantitatively
studied, large numbers of substrates to be assayed, and the
enzymes involved in the palmitoylation cycle identified. New
tools for real-time analysis are finally becoming available.
For example, it is now feasible to visualize the palmitoylated
form of a particular protein (Gao and Hannoush, 2014) and
assay depalmitoylation (Kathayat et al., 2017). Combining these
techniques with super-resolution microscopy will enable live
imaging of neuronal domains and organelles with new precision.
Multi-photon microscopy has been invaluable in studying a
wide range of structures from individual spines to neuronal
circuitry. Applications of these new technologies will create
exciting opportunities to tackle the above and other questions.
Newmechanistic details of about palmitoylation cycle and its role
in synaptic development and plasticity should emerge and may
provide insights into the pathology of various neurological and
psychiatric disorders in children and adults.
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